Zeven
Trade names[edit | edit source]
Dalvance, Xydalba, Zeven
Other names[edit | edit source]
Dalbavancin
Dalvance is indicated for acute bacterial skin and skin structure infections (absssi) caused by designated susceptible strains of gram-positive microorganisms.
Usage[edit | edit source]
To reduce the development of drug-resistant bacteria and maintain the effectiveness of dalvance and other antibacterial drugs, dalvance should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.
Dosage [edit | edit source]
- Two-dose regimen: 1000 mg followed one week later by 500 mg
- Dosage adjustment for patients with creatinine clearance less than 30 ml/min and not receiving regularly scheduled hemodialysis: 750 mg followed one week later by 375 mg.
Adminstration[edit | edit source]
Administer by intravenous infusion over 30 minutes.
Dosage forms and strengths[edit | edit source]
For injection: 500 mg of lyophilized powder in a single-use vial for reconstitution
contraindications[edit | edit source]
Hypersensitivity to dalbavancin
- serious hypersensitivity (anaphylactic) and skin reactions have been reported with glycopeptide antibacterial agents, including dalvance; exercise caution in patients with known hypersensitivity to glycopeptides.
- Rapid intravenous infusion of glycopeptide antibacterial agents can cause reactions.
- Alt elevations with dalvance treatment were reported in clinical trials.
- Clostridium difficile-associated diarrhea (cdad) has been reported with nearly all systemic antibacterial agents, including dalvance. Evaluate if diarrhea occurs.
Adverse reactions[edit | edit source]
The most common adverse reactions in patients treated with dalvance were nausea (5.5%), headache (4.7%), and diarrhea (4.4%).
Drug interactions [edit | edit source]
No clinical drug-drug interaction studies have been conducted with dalvance. There is minimal potential for drug-drug interactions between dalvance and cytochrome p450 (cyp450) substrates, inhibitors, or inducers
| Zeven Resources | |
|---|---|
|
 |
| Zeven Resources | |
|---|---|
|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju
